Skip to main content
. 2021 Jul 21;12(1):4004–4015. doi: 10.1080/21655979.2021.1951070

Figure 3.

Figure 3.

H19 sponged miR-106b-5p in BMVECs

(a) Bioinformatic analysis predicted the binding sites between miR-106b-5p and H19. (b) Dual-luciferase reporter assays confirmed that miR-106b-5p was a target of H19 in BMVECs. (c) Interactions between miR-106b-5p and H19 were determined using RNA pull-down assays. *P < 0.05 (d) The expression of miR-106b-5p was determined by RT-qPCR. (E) miR-106b-5p expression levels in BMVECs treated with or without OGD/H. *P < 0.05, **P < 0.01, ##P < 0.01.